What is a stock summary page? Click here for an overview.
Business Description
Aelis Farma SA
ISIN : FR0014007ZB4
Compare
Compare
Traded in other countries / regions
AELIS.France69O.Germany IPO Date
2022-02-18Description
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.48 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | -0.64 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.12 | |||||
| Beneish M-Score | -0.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -5.9 | |||||
| 3-Year EPS without NRI Growth Rate | -22.4 | |||||
| 3-Year FCF Growth Rate | -56.8 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 81.26 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.38 | |||||
| 9-Day RSI | 54.55 | |||||
| 14-Day RSI | 47.19 | |||||
| 3-1 Month Momentum % | -26.42 | |||||
| 6-1 Month Momentum % | -63.59 | |||||
| 12-1 Month Momentum % | -89.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.97 | |||||
| Cash Ratio | 1.99 | |||||
| Days Sales Outstanding | 80.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.2 | |||||
| Shareholder Yield % | -3.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -103.76 | |||||
| Net Margin % | -100.03 | |||||
| FCF Margin % | -160.93 | |||||
| ROE % | -55.58 | |||||
| ROA % | -27.74 | |||||
| ROIC % | -106.36 | |||||
| 3-Year ROIIC % | -95.14 | |||||
| ROC (Joel Greenblatt) % | -505.75 | |||||
| ROCE % | -46.68 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.36 | |||||
| PS Ratio | 2.01 | |||||
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 1.72 | |||||
| EV-to-EBIT | -1.23 | |||||
| EV-to-EBITDA | -1.23 | |||||
| EV-to-Revenue | 1.32 | |||||
| EV-to-FCF | -0.67 | |||||
| Price-to-Net-Current-Asset-Value | 2.05 | |||||
| Price-to-Net-Cash | 7.94 | |||||
| Earnings Yield (Greenblatt) % | -81.12 | |||||
| FCF Yield % | -69.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aelis Farma SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7.454 | ||
| EPS (TTM) (€) | -0.556 | ||
| Beta | 0.62 | ||
| 3-Year Sharpe Ratio | -0.79 | ||
| 3-Year Sortino Ratio | -0.99 | ||
| Volatility % | 104.63 | ||
| 14-Day RSI | 47.19 | ||
| 14-Day ATR (€) | 0.189597 | ||
| 20-Day SMA (€) | 1.16825 | ||
| 12-1 Month Momentum % | -89.08 | ||
| 52-Week Range (€) | 1 - 13.3 | ||
| Shares Outstanding (Mil) | 13.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aelis Farma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aelis Farma SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aelis Farma SA Frequently Asked Questions
What is Aelis Farma SA(XPAR:AELIS)'s stock price today?
The current price of XPAR:AELIS is €1.27. The 52 week high of XPAR:AELIS is €13.30 and 52 week low is €1.00.
When is next earnings date of Aelis Farma SA(XPAR:AELIS)?
The next earnings date of Aelis Farma SA(XPAR:AELIS) is .
Does Aelis Farma SA(XPAR:AELIS) pay dividends? If so, how much?
Aelis Farma SA(XPAR:AELIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers